Report Code : CVMI1604202502 | Published Date : April 16, 2025
The global veterinary surgical robotics market was valued at USD 220 million in 2023 and is projected to grow at a remarkable CAGR of 28.4% through 2031, reaching USD 1.5 billion. This significant growth is driven by:
- Precision surgery demand shows a 90% reduction in complication rates compared to traditional methods.
- Shortage of veterinary specialists (robot-assisted surgery requires 40% fewer staff)
- Pet insurance coverage expansion: 55% now cover robotic procedures.
Technology Segments:
- Fully Robotic Systems (45% share) - USD 1M+ da Vinci-style platforms
- Handheld Robotic Assist (XX%) - 150 K- 150 K- 500 K systems
- AI Guidance Platforms (XX%) - Augmented Reality Navigation
Key Applications:
- Soft Tissue (55%) - Spays, tumor resections
- Orthopedics (30%) - TPLO, joint replacements
- Neurology (10%) - Spinal procedures
- Other (5%)
Growth Accelerators
1. Unparalleled Surgical Precision
- Submillimeter accuracy for microsurgery
- Tremor filtration facilitates delicate nerve repairs.
- Real-time tissue analytics using hyperspectral imaging
2. Economic Benefits
- 30% faster procedure times increase throughput
- 14% increase in case acceptance when offering robotic options
- Two-year ROI for high-volume specialty centers
3. Telerobotic Potential
- Remote specialist support for rural clinics
- Veterinary teaching hospitals that adopt dual-console training
4. Regulatory Tailwinds
- FDA's 2023 Veterinary Robotics Pathway
- AAHA's Surgical Standards Update (2024)
Regional Adoption Landscape
Region |
Market Share |
Key Development |
North America |
58% |
75% of veterinary teaching hospitals equipped |
Europe |
XX% |
CE Mark approvals accelerating |
Asia-Pacific |
XX% |
China's "Smart Vet 2030" initiative |
Latin America |
XX% |
Brazil's first robotic surgery center (2024) |
Pioneer Case:
- University of Pennsylvania's Robotic Spay Program reduced complications by 92%
Competitive Frontier
Market Leaders:
- MediRobotics Vet (40%) - FlexDex platform (USD 350K)
- CUREVET (XX%) - da Vinci Vet adaptation
- SurgicalAR (XX%) - AI-guided navigation
- VetBotics (XX%) - Canine-specific microsurgery
- OrthoPets Robotic (XX%) - TPLO automation
2024 Breakthroughs:
- First autonomous suturing FDA clearance
- Neuralink-style robotic scrub nurse prototype
Reasons To Buy

Scope

- MediRobotics Vet
- CUREVET
- SurgicalAR
- VetBotics
- OrthoPets Robotic
